1.Abdominal Obesity, Insulin Resistance, and the Risk of Colonic Adenoma.
Hang Lak LEE ; Byoung Kwan SON ; Oh Young LEE ; Yong Chul JEON ; Dong Soo HAN ; Ju Hyun SOHN ; Byung Chul YOON ; Ho Soon CHOI ; Joon Soo HAHM ; Min Ho LEE ; Dong Hoo LEE ; Chun Suk KEE
The Korean Journal of Gastroenterology 2007;49(3):147-151
BACKGROUND/AIMS: Abdominal obesity and hyperinsulinemia or insulin resistance are of interest in connection with colon carcinogenesis. We conducted a prospective case controlled study for the evaluation of relationship between abdominal obesity, insulin resistance, and colorectal adenoma. METHODS: Fifty patients with colorectal adenoma and fifty healthy subjects were included in this study. Total colonoscopic examinations were performed in all the subjects. Fasting blood sugar (FBS), insulin, homeostasis model assessment (HOMA-IR), triglyceride (TG), cholesterol (CROL), BMI (body mass index), WHR (waist hip ratio), percent body fat (PBF) and obesity degree (OD) were measured. HOMA-IR was considered to represent insulin resistance. Diabetic patients were excluded from this study. RESULTS: There were no differences in sex, serum insulin, FBS, HOMA-IR, TG, CROL between adenoma and control group. Subjects with high BMI, WHR, percent body fat, and obesity were more likely to have colonic adenoma. Multiple logistic regression analysis after adjusting confounding factors, had revealed that WHR was the most important independent risk factor for colon adenoma. CONCLUSIONS: Abdominal obesity was most closely related to colonic adenoma. However, insulin resistance was not related to colonic adenoma. A larger case controlled study is needed.
*Abdominal Fat
;
Adenoma/diagnosis/epidemiology/*etiology
;
Aged
;
Body Fat Distribution
;
Body Mass Index
;
Colonic Neoplasms/diagnosis/epidemiology/*etiology
;
Colonoscopy
;
Female
;
Humans
;
*Insulin Resistance
;
Male
;
Middle Aged
;
Obesity/*complications/epidemiology/pathology
;
Risk Factors
;
Waist-Hip Ratio
2.The Risk of Metachronous Advanced Colorectal Neoplasia Rises in Parallel with an Increasing Number of High-Risk Findings at Baseline.
Seung Min LEE ; Jeong Hwan KIM ; In Kyung SUNG ; Sung Noh HONG
Gut and Liver 2015;9(6):741-749
BACKGROUND/AIMS: Colorectal adenomas that are > or =10 mm have villous histology or high-grade dysplasia, or that are associated with > or =3 adenomas are considered high-risk for metachronous advanced neoplasia. We evaluated the cumulative incidence of metachronous advanced neoplasia according to the total number of high-risk findings detected on baseline colonoscopy. METHODS: This was a retrospective cohort study performed in 862 patients who underwent removal of colorectal adenomas between 2005 and 2009. At least one surveillance colonoscopy had been conducted at Konkuk University Medical Center, Seoul, Korea. RESULTS: The cumulative incidence of metachronous advanced neoplasia in patients with 0, 1, 2, and 3-4 high-risk findings at 1 year were 0.7%, 1.3%, 2.8%, and 8.0%; at 3 years, those were 5.9%, 11.9%, 15.5%, and 24.7%; and at 5 years, those were 8.5%, 18.7%, 26.3%, and 37.2%, respectively. In a multivariate model, the risk of metachronous advanced neoplasia was significantly higher for the multiple high-risk findings group when compared with the 0 high-risk findings group (1 high-risk (+): hazard ratio, 1.86 [95% confidence interval, 1.00-3.44]; 2 high-risk (+): 1.84 [0.88-3.84]; and 3-4 high-risk (+): 3.29 [1.54-7.01]; ptrend=0.020). CONCLUSIONS: The presence of overlapping multiple high-risk findings was associated with an increased risk of advanced neoplasia during surveillance.
Adenoma/epidemiology/*etiology/pathology
;
Aged
;
Colonic Polyps/complications/surgery
;
*Colonoscopy
;
Colorectal Neoplasms/epidemiology/*etiology/pathology
;
Early Detection of Cancer/methods
;
Female
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Neoplasm Grading
;
Neoplasms, Second Primary/epidemiology/*etiology/pathology
;
Population Surveillance/methods
;
Proportional Hazards Models
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Risk Factors
;
Time Factors
;
Tumor Burden